Campbell & Co Investment Adviser’s PharMerica Corporation PMC Stock Holding History

Campbell & Co Investment Adviser’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-28,592	Closed	-$592K	–	316
2014 Q4	$592K	Buy	+28,592	New	+$679K	0.36%	103

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

CCM

Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return

LCP

Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Campbell & Co Investment Adviser's PMC Position: Q1 2015 in Review

Campbell & Co Investment Adviser sold out of PharMerica Corporation (PMC) in Q1 2015, closing a stake of 28,592 shares — an estimated $592K sold.

Campbell & Co Investment Adviser first reported a position in PMC in Q4 2014 and held it in 1 quarter. The position peaked at $592K in Q4 2014. 158 funds tracked by Wall St. Rank hold PMC as of Q1 2015.

Campbell & Co Investment Adviser reported no remaining PharMerica Corporation position as of Q1 2015 after selling out during the quarter.
Campbell & Co Investment Adviser sold 28,592 PharMerica Corporation shares in Q1 2015, an estimated $592K.
Campbell & Co Investment Adviser first reported a position in PharMerica Corporation in Q4 2014 and held it in 1 quarter.
Campbell & Co Investment Adviser's PharMerica Corporation position peaked at $592K in Q4 2014.
158 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2015.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2015, filed 13 May 2015.